EOS imaging’s hipEOS receives FDA approval

EOS imaging’s hipEOS has received approval from the U.S. Food and Drug Administration.

Advertisement

hipEOS is a 3D hip arthroplasty planning software based on EOS’ stereo-radiographic 2D/3D imaging. The software enables surgeons to perform pre-surgical planning including hip implant selection and virtual positioning in functional, weight-bearing 3D.

 

hipEOS received a CE Mark in March 2014 and will be launched in the U.S. in March next year.

More articles on devices:

The future of big orthopedic device companies: Boom or bust?
Stock report: 6 spine, orthopedic device company updates
MiMedx increases 2015 revenue projections by at least 50% — 5 key updates

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.